Product
MBF-RIC
1 clinical trial
1 indication
Indication
Disease-Free SurvivalClinical trial
A Multiple-center Phase II Study to Evaluate the Clinical Outcome of Reduced Conditioning Regimen With Melphalan, Busulfan and Fludarabine for Patients >=55 Years With Myeloid Malignancies.Status: Recruiting, Estimated PCD: 2024-06-01